Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 408NIH 109INDUSTRY 65NETWORK 64OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Brain Neoplasms 23Glioma 16Glioblastoma 12Meningeal Carcinomatosis 6Pheochromocytoma 5Paraganglioma 5Neurofibromatosis 1 4Spinal Cord Neoplasms 3Neoplasms 3Medulloblastoma 3Hemangioma, Capillary 3Carcinoma, Non-Small-Cell Lung 3Arteriovenous Malformations 3Radiation Injuries 2Neurologic Manifestations 2Meningioma 2Cerebral Hemorrhage 2Central Nervous System Neoplasms 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spinal Injuries 1Skull Base Neoplasms 1Salivary Gland Neoplasms 1Pemphigus 1Pemphigoid, Benign Mucous Membrane 1Neuroma, Acoustic 1Neurofibromatosis 2 1Neuroblastoma 1Muscle Weakness 1Motor Activity 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Neuroblastoma × CNS × Clear all
NCT01373736 2011-06-15

123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors

Vancouver Coastal Health

Phase 3 Unknown
CNSEndocrine

Carcinoid Tumor, Neuroblastoma, Paraganglioma, Pheochromocytoma, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡